Buy Zydus Lifesciences; target of Rs 1100: Sharekhan
Sharekhan is bullish on Zydus Lifesciences has recommended buy rating on the stock with a target price of Rs 1100 in its research report dated March 20, 2024.21-03-2024
Buy Zydus Lifesciences; target of Rs 1100: Sharekhan
Sharekhan is bullish on Zydus Lifesciences has recommended buy rating on the stock with a target price of Rs 1100 in its research report dated March 20, 2024.Zydus Lifesciences rises 2% on launch of cancer drug Olaparib
The drug will target specific genetic mutations prevalent in certain types of cancers, paving the way for more tailored and effective treatment approach.ZYDUS WELLNESS LTD.-$ - 531335 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Zydus Family Trust & PACsZYDUS WELLNESS LTD.-$ - 531335 - Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015
Disclosure under SEBI (PIT) Regulations, 2015ZYDUS WELLNESS LTD.-$ - 531335 - Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015
Disclosure under SEBI (PIT) Regulations, 2015Buy Zydus Lifesciences; target of Rs 1006: KR Choksey
KR Choksey is bullish on Zydus Lifesciences has recommended buy rating on the stock with a target price of Rs 1006 in its research report dated March 06, 2024.ZYDUS WELLNESS LTD.-$ - 531335 - Announcement under Regulation 30 (LODR)-Change in Management
Change in Senior ManagementZydus Lifesciences' Rs 600 Crore Buyback Offer To Open On Feb 29
Zydus Lifesciences' Rs 600 crore buyback offer for 59.7 lakh shares at Rs 1,005 each opens on Feb 29 and closes on March 6, 2024.ZYDUS WELLNESS LTD.-$ - 531335 - Reply To Clarification Sought On Increase In Volume Of Shares
Reply to clarification sought on increase in volume of sharesZYDUS WELLNESS LTD.-$ - 531335 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Zydus Family Trust & PACs